AWM
CTSO icon

Adams Wealth Management’s Cytosorbents Corp CTSO Stock Holding History

Adams Wealth Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-400
Closed -$3K – 129
2020
Q3 		$3K Buy
+400
New +$3.61K ﹤0.01% 257

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Adams Wealth Management's CTSO Position: Q4 2020 in Review

Adams Wealth Management sold out of Cytosorbents Corp (CTSO) in Q4 2020, closing a stake of 400 shares — an estimated $3K sold.

Adams Wealth Management first reported a position in CTSO in Q3 2020 and held it in 1 quarter. The position peaked at $3K in Q3 2020. 94 funds tracked by Wall St. Rank hold CTSO as of Q4 2020.

  • Adams Wealth Management reported no remaining Cytosorbents Corp position as of Q4 2020 after selling out during the quarter.
  • Adams Wealth Management sold 400 Cytosorbents Corp shares in Q4 2020, an estimated $3K.
  • Adams Wealth Management first reported a position in Cytosorbents Corp in Q3 2020 and held it in 1 quarter.
  • Adams Wealth Management's Cytosorbents Corp position peaked at $3K in Q3 2020.
  • 94 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2020.

Based on Adams Wealth Management's 13F filing for Q4 2020, filed 8 Feb 2021.